Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1730421000168117 | emtricitabine + rilpivirine + tenofovir disoproxil (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1730431000168119 | tenofovir disoproxil + emtricitabine + rilpivirine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir disoproxil + emtricitabine + rilpivirine | Is a | rilpivirine | true | Inferred relationship | Some | ||
| tenofovir disoproxil + emtricitabine + rilpivirine | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 2 | |
| tenofovir disoproxil + emtricitabine + rilpivirine | has intended active ingredient | rilpivirine | true | Inferred relationship | Some | 3 | |
| tenofovir disoproxil + emtricitabine + rilpivirine | has intended active ingredient | tenofovir disoproxil | true | Inferred relationship | Some | 1 | |
| tenofovir disoproxil + emtricitabine + rilpivirine | Is a | tenofovir disoproxil + emtricitabine | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet (medicinal product unit of use) | Is a | True | tenofovir disoproxil + emtricitabine + rilpivirine | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Medicinal product reference set
FHIR